Chawana T D, Reid A, Bwakura T, Gavi S, Nhachi C F B
Cent Afr J Med. 2014 May-Aug;60(5-8):29-36.
Risk factors for treatment failure in HIV positive adults have not been studied extensively in Zimbabwe.
To investigate socio-demographic, psychosocial and antiretroviral drug related factors as possible risk factors for treatment failure.
To compare the accuracy and reliability of CD4 count results in diagnosing treatment failure versus viral load results.
A descriptive cross-sectional survey.
Harare Central Hospital adult opportunistic infections clinic.
One hundred and eighteen (118) HIV positive participants on 1st line antiretroviral therapy (any 1 of stavudine, tenofovir or zidovudine combined with lamivudine and nevirapine or efavirenz) for at least 1 year. Participants were conveniently sampled.
First line treatment failure as defined according to World Health Organisation (WHO) 2010 guidelines.
Factors associated with higher odds of treatment failure were severe depression [OR 3.7; p-value 0.002; 95% CI 1.6-8.5] and discontinuing ART [OR 4.4; p-value 0.02; 95% CI 1.3-14.7]. Factors associated with lower odds of treatment failure were age = 42 [OR 0.3; p-value 0.007; 95% CI 0.1-0.7], taking ART on time [OR 0.2; p-value 0.02; 95% CI 0.05-0.8], time on ART > 4 years [OR 0.6; p-value 0.02; 95% CI 0.3-0.9] and female sex [OR 0.4; p-value 0.02; 95% CI 0.2-0.8]. There was statistically significant difference between CD4 count and viral load results in diagnosing treatment failure [OR 8.7; p-value 0.0005; 95% CI 3.6-21.2].
Severe depression and discontinuing ART predisposed to treatment failure. CD4 counts were not as reliable as viral load measurements in diagnosing treatment failure.
在津巴布韦,尚未对艾滋病毒阳性成年人治疗失败的风险因素进行广泛研究。
调查社会人口学、心理社会及抗逆转录病毒药物相关因素,作为治疗失败的可能风险因素。
比较CD4细胞计数结果与病毒载量结果在诊断治疗失败方面的准确性和可靠性。
描述性横断面调查。
哈拉雷中心医院成人机会性感染诊所。
118名接受一线抗逆转录病毒治疗(司他夫定、替诺福韦或齐多夫定中的任何一种与拉米夫定及奈韦拉平或依非韦伦联合使用)至少1年的艾滋病毒阳性参与者。采用方便抽样法选取参与者。
根据世界卫生组织(WHO)2010年指南定义的一线治疗失败。
与治疗失败几率较高相关的因素为重度抑郁[比值比(OR)3.7;p值0.002;95%置信区间(CI)1.6 - 8.5]及停止抗逆转录病毒治疗[OR 4.4;p值0.02;95% CI 1.3 - 14.7]。与治疗失败几率较低相关的因素为年龄 = 42岁[OR 0.3;p值0.007;95% CI 0.1 - 0.7]、按时接受抗逆转录病毒治疗[OR 0.2;p值0.02;95% CI 0.05 - 0.8]、接受抗逆转录病毒治疗时间>4年[OR 0.6;p值0.02;95% CI 0.3 - 0.9]及女性[OR 0.4;p值0.02;95% CI 0.2 - 0.8]。在诊断治疗失败方面,CD4细胞计数结果与病毒载量结果之间存在统计学显著差异[OR 8.7;p值0.0005;95% CI 3.6 - 21.2]。
重度抑郁和停止抗逆转录病毒治疗易导致治疗失败。在诊断治疗失败方面,CD4细胞计数不如病毒载量测量可靠。